TherapeuticsMD, Inc. (TXMD) News
Track canonical SquawkNews coverage tagged to TXMD, TherapeuticsMD, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY
TherapeuticsMD (NASDAQ: TXMD ) reported quarterly earnings of $0.01 per share. This is a 80 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $869.000 thousand in sale
EARNINGS | Aug 11, 2026, 08:30 PM UTC
L
TXMD - TherapeuticsMD Announces Second Quarter 2026 Financial Results
TXMD - TherapeuticsMD Announces Second Quarter 2026 Financial Results
EARNINGS | Aug 11, 2026, 08:08 PM UTC